Collegium Pharmaceutical, Inc.(COLL)

A specialty pharmaceutical company

1 Insight

Investment Insights

AI-generated insights about Collegium Pharmaceutical, Inc. from various financial sources

Thursday, September 4, 2025

Very Bearish

The Chief Medical Officer made his largest-ever sale ($671,000) after a 30% stock price increase, suggesting he is taking profits. His previous sales were followed by significant declines.